Quick Answer
NOVAVAX INC reported Net Income of $440.30 million for fiscal year 2025.
NOVAVAX INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $440.30M | +334.8% |
| 2024 | -$187.50M | +65.6% |
| 2023 | -$545.06M | +17.2% |
| 2022 | -$657.94M | +62.3% |
| 2021 | -$1.74B | -316.9% |
| 2020 | -$418.26M | -215.2% |
| 2019 | -$132.69M | +28.2% |
| 2018 | -$184.75M | -0.5% |
| 2017 | -$183.77M | +34.4% |
| 2016 | -$279.97M | -78.4% |
| 2015 | -$156.94M | -89.2% |
| 2014 | -$82.95M | -59.6% |
| 2013 | -$51.98M | -82.4% |
| 2012 | -$28.51M | -47.2% |
| 2011 | -$19.36M | +45.8% |
| 2010 | -$35.71M | +11.5% |
| 2009 | -$40.35M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$202.38M | -66.8% | -290.0% |
| June 30, 2025 | $106.51M | -34.4% | -79.5% |
| March 31, 2025 | $518.65M | +451.5% | +527.6% |
| September 30, 2024 | -$121.30M | +7.2% | -174.7% |
| June 30, 2024 | $162.38M | +179.9% | +210.1% |
| March 31, 2024 | -$147.55M | +49.8% | -12.8% |
| September 30, 2023 | -$130.78M | +22.4% | -325.4% |
| June 30, 2023 | $58.01M | +111.4% | +119.7% |
- NOVAVAX INC showed an increase of +334.8% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, NOVAVAX INC’s net income has grown by 1191.3% (from -$40.35 million to $440.30 million).
- The most recent figure is from NOVAVAX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: